CN101974463A - Lactobacillus reuteri and composite viable bacteria preparation thereof - Google Patents
Lactobacillus reuteri and composite viable bacteria preparation thereof Download PDFInfo
- Publication number
- CN101974463A CN101974463A CN2010105174270A CN201010517427A CN101974463A CN 101974463 A CN101974463 A CN 101974463A CN 2010105174270 A CN2010105174270 A CN 2010105174270A CN 201010517427 A CN201010517427 A CN 201010517427A CN 101974463 A CN101974463 A CN 101974463A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus reuteri
- bacteria
- bacillus natto
- bacterial
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 74
- 241000186604 Lactobacillus reuteri Species 0.000 title claims abstract description 35
- 229940001882 lactobacillus reuteri Drugs 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 49
- 239000002131 composite material Substances 0.000 title abstract description 6
- 239000003674 animal food additive Substances 0.000 claims abstract description 7
- 238000004321 preservation Methods 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 29
- 230000001580 bacterial effect Effects 0.000 claims description 22
- 241000186000 Bifidobacterium Species 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 244000063299 Bacillus subtilis Species 0.000 claims description 17
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 17
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 230000000813 microbial effect Effects 0.000 claims description 9
- 239000002054 inoculum Substances 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 235000020183 skimmed milk Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 230000028070 sporulation Effects 0.000 claims description 2
- 230000003068 static effect Effects 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000010802 sludge Substances 0.000 claims 2
- 238000011068 loading method Methods 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 8
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 229940088710 antibiotic agent Drugs 0.000 abstract description 4
- 235000021052 average daily weight gain Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 24
- 239000002609 medium Substances 0.000 description 20
- 230000002354 daily effect Effects 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 238000007689 inspection Methods 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000006041 probiotic Substances 0.000 description 6
- 235000018291 probiotics Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 235000021051 daily weight gain Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000009629 microbiological culture Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000014590 basal diet Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940004120 bifidobacterium infantis Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108050008938 Glucoamylases Proteins 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- -1 vitamin B1 Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Abstract
本发明提供一种罗伊氏乳杆菌(Lactobacillus reuteri)L-HD5及其复合活菌制剂,其保藏编号为CGMCC No.4050。本发明的活菌制剂作为饲料添加剂,经饲养后可显著提高断奶仔猪头均日增重及饲料效率,降低仔猪腹泻率,提高经济效益。具有推广应用前景,并且为寻求抗生素替代品提供了一定的理论与实践基础。The invention provides Lactobacillus reuteri L-HD5 and its composite live bacteria preparation, and its preservation number is CGMCC No.4050. As a feed additive, the living bacteria preparation of the invention can significantly increase the average daily weight gain and feed efficiency of weaned piglets after feeding, reduce the diarrhea rate of piglets, and improve economic benefits. It has a prospect of popularization and application, and provides a certain theoretical and practical basis for seeking alternatives to antibiotics.
Description
技术领域technical field
本发明涉及属于微生态制剂技术领域,具体地说是涉及一种罗伊氏乳杆菌及其复合活菌制剂。The invention relates to the technical field of microecological preparations, in particular to a Lactobacillus reuteri and a composite live bacteria preparation thereof.
背景技术Background technique
复合活菌制剂做为微生态制剂的一种,已被广泛应用于畜牧业养殖。其主要由两种或两种以上的不同益生菌菌属组成。目前,通常应用的菌种主要是乳酸杆菌、双歧杆菌、粪链球菌、芽孢杆菌及酵母菌等。将具有不同生物功能的益生菌组合,研制的复合活菌制剂通过生物拮抗作用、生物夺氧用及及增强免疫等作用以维持胃肠道内环境平衡,且益生菌可在动物机体内生长代谢,产生的各种消化酶能明显加强机体对饲料中各种营养成分的消化吸收,提高饲料的利用。As a kind of microecological preparation, compound live bacteria preparation has been widely used in animal husbandry. It mainly consists of two or more different genera of probiotic bacteria. At present, the commonly used strains are mainly Lactobacillus, Bifidobacterium, Streptococcus faecalis, Bacillus and yeast. Combining probiotics with different biological functions, the compound live bacterial preparation developed can maintain the balance of the gastrointestinal environment through biological antagonism, biological oxygen capture and immune enhancement, and the probiotics can grow and metabolize in the animal body. The various digestive enzymes produced can significantly strengthen the body's digestion and absorption of various nutrients in the feed and improve the utilization of the feed.
目前,应用于猪的复合活菌制剂生产菌株中,大部分为非猪源益生菌,由于动物肠道菌群的生成是长期进化的结果,一种适于某类动物的微生态制剂不一定适于另一类动物,从而导致应用效果受到较大影响。At present, most of the production strains of compound living bacteria preparations used in pigs are non-pig-derived probiotics. Since the formation of animal intestinal flora is the result of long-term evolution, a microecological preparation suitable for a certain type of animal may not be Suitable for another type of animal, resulting in a greater impact on the application effect.
罗伊氏乳杆菌(Lactobacillus reuteri)是健康仔猪胃肠道的常在菌,国外研究报道表明,罗伊氏乳杆菌对胃酸及胆汁具有较强的耐受能力,能够保持活力直达胃肠道,并且还能分泌特殊的抗菌物质Reuterin,有效抑制轮状病毒及其他肠道病原微生物的生长,从而来预防和治疗腹泻。该菌已被国内外学者广泛地应用于饲用微生态制剂,具有很好的市场前景。Lactobacillus reuteri is a common bacterium in the gastrointestinal tract of healthy piglets. Foreign research reports have shown that Lactobacillus reuteri has strong tolerance to gastric acid and bile, and can maintain vitality directly to the gastrointestinal tract. And it can also secrete special antibacterial substance Reuterin, which can effectively inhibit the growth of rotavirus and other intestinal pathogenic microorganisms, so as to prevent and treat diarrhea. The bacterium has been widely used in feed microecological preparations by scholars at home and abroad, and has a good market prospect.
双歧杆菌是人和动物肠道内最主要的生理性细菌之一,与其它生理性细菌成员构成了微生物群落,并与宿主构成一个微生态系统。双歧杆菌进入肠道后迅速在肠粘膜定植,并与肠粘膜上皮细胞结合形成微生物膜,阻止致病菌的定植与入侵;同时,产生大量的乳酸与乙酸,改善肠内环境,维持正常的肠蠕动,促使致病菌排出体外;直接抑制或拮抗痢疾杆菌、伤寒杆菌、绿脓杆菌、致病性大肠杆菌、葡萄球菌等致病菌的生长。双歧杆菌可清除致病菌所释放的有毒有害代谢产物,减少内毒素来源,抑制致病菌群生长,降低血中内毒素水平,调整微生态平衡,防治内毒素血症。双歧杆菌也能合成多种维生素(如维生素B1、B2、B6、B12、烟酸、叶酸等)和生物酶;使肠道酸化,有利于铁、钙及维生素D的吸收,防止缺铁性贫血及维生素D缺乏症的发生;能补充多种氨基酸和微量元素。能激活机体吞噬细胞的吞噬能力,增强机体的抗病免疫功能。由于双歧杆菌具有维持微生态平衡、生物拮抗、免疫调节、营养等多方面的益生性能,目前已被广泛应用于微生物饲料添加剂、医疗、保健、食品等领域,在国内外受到了研究者和消费者的青睐。Bifidobacterium is one of the most important physiological bacteria in the intestinal tract of humans and animals. It forms a microbial community with other physiological bacterial members and forms a microecosystem with the host. Bifidobacteria quickly colonize the intestinal mucosa after entering the intestinal tract, and combine with intestinal mucosal epithelial cells to form a microbial film to prevent the colonization and invasion of pathogenic bacteria; at the same time, a large amount of lactic acid and acetic acid are produced to improve the intestinal environment and maintain normal Intestinal peristalsis promotes the excretion of pathogenic bacteria; directly inhibits or antagonizes the growth of Shigella, Salmonella typhi, Pseudomonas aeruginosa, pathogenic Escherichia coli, Staphylococcus and other pathogenic bacteria. Bifidobacteria can remove the toxic and harmful metabolites released by pathogenic bacteria, reduce the source of endotoxin, inhibit the growth of pathogenic bacteria, reduce the level of endotoxin in the blood, adjust the micro-ecological balance, and prevent and treat endotoxemia. Bifidobacteria can also synthesize a variety of vitamins (such as vitamin B1, B2, B6, B12, niacin, folic acid, etc.) and biological enzymes; acidify the intestinal tract, which is beneficial to the absorption of iron, calcium and vitamin D, and prevent iron deficiency Occurrence of anemia and vitamin D deficiency; can supplement a variety of amino acids and trace elements. It can activate the phagocytic ability of the body's phagocytic cells and enhance the body's anti-disease immune function. Bifidobacteria have been widely used in microbial feed additives, medical care, health care, food and other fields because of their beneficial properties in maintaining micro-ecological balance, biological antagonism, immune regulation, and nutrition. favored by consumers.
另外,经国内外学者研究发现,芽孢杆菌属中的纳豆芽孢杆菌,由于其可产生芽孢,因而有耐酸、耐碱、耐高温及耐挤压等特点,在制粒过程及胃酸环境中均能保持高度的稳定性,是各种益生菌当中,对环境耐受力较好且可以直达小肠的菌种之一。此外,纳豆芽孢杆菌还能够生成多种蛋白酶、糖化酶、脂肪酶、淀粉酶,降解植物性饲料中某些复杂的碳水化合物,从而提高饲料的转化率,调节肠道菌群,增强动物的细胞免疫效应。In addition, domestic and foreign scholars have found that Bacillus natto in the genus Bacillus, because it can produce spores, has the characteristics of acid resistance, alkali resistance, high temperature resistance and extrusion resistance, and is stable in the granulation process and gastric acid environment. It can maintain a high degree of stability and is one of the strains that are more resistant to the environment and can directly reach the small intestine among various probiotics. In addition, Bacillus natto can also produce a variety of proteases, glucoamylases, lipases, and amylases to degrade some complex carbohydrates in plant feeds, thereby improving feed conversion rates, regulating intestinal flora, and enhancing animal health. cellular immune effects.
发明内容Contents of the invention
本发明的目的是提供一种罗伊氏乳杆菌以及由其制备的复合活菌制剂。The object of the present invention is to provide a kind of Lactobacillus reuteri and the compound living bacteria preparation prepared therefrom.
本发明另一个目的是提供所述罗伊氏乳杆菌及其复合菌剂的应用。Another object of the present invention is to provide the application of the Lactobacillus reuteri and its composite bacterial agent.
本发明的罗伊氏乳杆菌(Lactobacillus reuteri)L-HD5分离自猪肠道,该菌株已于2010年7月30日保藏于中国微生物菌种保藏管理委员会普通微生物中心(地址:北京市朝阳区北辰西路1号院3号,邮编100101),其简称为CGMCC,保藏编号为CGMCC No.4050。Lactobacillus reuteri (Lactobacillus reuteri) L-HD5 of the present invention is isolated from pig intestines, and this bacterial strain has been preserved in the General Microbiology Center of China Microbiological Culture Collection Management Committee (Address: Chaoyang District, Beijing) on July 30, 2010. No. 3, No. 1 Yard, Beichen West Road, Zip Code 100101), its abbreviation is CGMCC, and the preservation number is CGMCC No.4050.
本发明还提供含有罗伊氏乳杆菌(Lactobacillus reuteri)L-HD5的菌剂。The present invention also provides a bacterial agent containing Lactobacillus reuteri L-HD5.
所述菌剂还包括双歧杆菌和纳豆芽孢杆菌。The bacterial agent also includes bifidobacteria and bacillus natto.
优选地,所述菌剂按重量份计含有:Preferably, the bacterial agent contains by weight:
罗伊氏乳杆菌L-HD5 1-10份Lactobacillus reuteri L-HD5 1-10 copies
双歧杆菌 1-10份Bifidobacterium 1-10 copies
纳豆芽孢杆菌 1-10份。Bacillus natto 1-10 parts.
更优选地,所述菌剂按重量份计含有:More preferably, the bacterial agent contains by weight:
罗伊氏乳杆菌L-HD5 1份Lactobacillus reuteri L-HD5 1 part
双歧杆菌 1份Bifidobacterium 1 part
纳豆芽孢杆菌 1份。Bacillus natto 1 part.
本发明还提供含有罗伊氏乳杆菌(Lactobacillus reuteri)L-HD5或上述菌剂的饲料添加剂。The present invention also provides a feed additive containing Lactobacillus reuteri L-HD5 or the above bacteria agent.
本发明进一步提供制备上述菌剂的方法,包括下述步骤:将罗伊氏乳杆菌L-HD5、双歧杆菌和纳豆芽孢杆菌分别进行下述操作:进行液体深层发酵培养,离心处理后收集菌泥,再通过真空冷冻干燥技术制备并收集菌粉,最后将三种菌粉复配。The present invention further provides a method for preparing the above microbial agent, comprising the following steps: performing the following operations on Lactobacillus reuteri L-HD5, Bifidobacterium and Bacillus natto respectively: carrying out liquid submerged fermentation culture, and collecting after centrifugation bacteria slime, and then prepare and collect the bacteria powder by vacuum freeze-drying technology, and finally compound the three kinds of bacteria powder.
其中,所述罗伊氏乳杆菌L-HD5和双歧杆菌的发酵培养条件为:温度37℃,pH6.0~6.5,静止培养,装液量60%,接种量3%,培养时间16~24h,活菌数大于108CFU/mL。Wherein, the fermentation culture conditions of Lactobacillus reuteri L-HD5 and Bifidobacteria are: temperature 37°C, pH 6.0-6.5, static culture, liquid filling volume 60%, inoculum volume 3%, culture time 16-6. After 24 hours, the number of viable bacteria was greater than 10 8 CFU/mL.
所述纳豆芽孢杆菌的发酵培养条件为:温度37℃,pH6.0,搅拌转速180rpm,装液量20%,接种量3%,培养时间24~36h,活菌数大于108CFU/mL,芽孢形成率达到50%以上。The fermentation and cultivation conditions of Bacillus natto are as follows: temperature 37°C, pH 6.0, stirring speed 180rpm, liquid filling volume 20%, inoculum volume 3%, culture time 24-36h, and the number of viable bacteria is greater than 10 8 CFU/mL , The sporulation rate reaches more than 50%.
本发明还提供罗伊氏乳杆菌(Lactobacillus reuteri)L-HD5或上述菌剂在饲料添加剂中的应用。The present invention also provides the application of Lactobacillus reuteri L-HD5 or the above bacteria agent in feed additives.
本发明的复合活菌制剂作为饲料添加剂,经饲养后可显著提高断奶仔猪头均日增重及饲料效率,降低仔猪腹泻率,提高经济效益。具有推广应用前景,并且为寻求抗生素替代品提供了一定的理论与实践基础。As a feed additive, the compound living bacteria preparation of the invention can significantly increase the average daily head weight gain and feed efficiency of weaned piglets after feeding, reduce the diarrhea rate of piglets, and improve economic benefits. It has a prospect of popularization and application, and provides a certain theoretical and practical basis for seeking alternatives to antibiotics.
具体实施方式Detailed ways
以下实施例用于说明本发明,但不用来限制本发明的范围。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
实施例1:罗伊氏乳杆菌活菌制剂的制备Embodiment 1: Preparation of Lactobacillus reuteri live bacteria preparation
菌种活化Activation of strains
将罗伊氏乳杆菌冻干菌种(Lactobacillus reuteri L-HD5)划线接种于MRS固体培养基(北京陆桥技术有限责任公司生产,批号为:CM188)表面,37℃厌氧培养16~24h,直至固体培养基表面长出菌落,镜检观察菌体形态及纯度。Streak inoculation of Lactobacillus reuteri L-HD5 on the surface of MRS solid medium (produced by Beijing Land Bridge Technology Co., Ltd., batch number: CM188), and anaerobic culture at 37°C for 16-24h, Until bacterial colonies grow on the surface of the solid medium, observe the morphology and purity of the bacteria by microscopic examination.
种子液的制备Preparation of seed solution
挑取MRS固体培养基表面菌落,接种于装有5mL种子培养基的试管中,37℃厌氧培养16~24h,待活菌数达108CFU/mL,按2%(约1×106CFU/mL)接种量接种于装有150mL种子培养基的250mL锥形瓶中,37℃厌氧培养16~24h,待活菌数达108CFU/mL,作为种子液备用。Pick the colonies on the surface of the MRS solid medium, inoculate them into a test tube containing 5 mL of seed medium, and incubate anaerobically at 37 °C for 16-24 hours . CFU/mL) inoculum amount was inoculated into a 250mL Erlenmeyer flask containing 150mL seed medium, anaerobically cultured at 37°C for 16-24h, until the number of viable bacteria reached 10 8 CFU/mL, it was used as a seed solution for later use.
种子培养基组成如下:蛋白胨10g,牛肉膏15g,酵母粉5g,葡萄糖15g,柠檬酸二铵2g,乙酸钠5g,吐温801mL,K2HPO42g,MgSO4·7H2O 0.5g,MnSO4·4H2O 0.2g,蒸馏水加至1000mL。The composition of the seed medium is as follows: peptone 10g, beef extract 15g, yeast powder 5g, glucose 15g, diammonium citrate 2g, sodium acetate 5g, Tween 801mL, K 2 HPO 4 2g, MgSO 4 7H 2 O 0.5g, MnSO 4 ·4H 2 O 0.2g, add distilled water to 1000mL.
液体深层发酵培养liquid submerged fermentation culture
选用5L立式发酵罐进行液体发酵培养。其中,罗伊氏乳杆菌种子液的接种量为3%,装液量为60%,37℃厌氧培养20h后,测定每毫升菌液中的活菌数,待活菌数达109CFU/mL,放罐结束发酵培养。A 5L vertical fermenter was selected for liquid fermentation culture. Among them, the inoculum amount of Lactobacillus reuteri seed solution is 3%, and the filling volume is 60%. After anaerobic culture at 37°C for 20 hours, measure the number of viable bacteria per milliliter of the bacterial solution until the number of viable bacteria reaches 10 9 CFU /mL, put the tank to end the fermentation culture.
发酵培养基组成如下:大豆蛋白胨50g,葡萄糖10g,酵母粉17g,低聚糖3g,蒸馏水加至1000mL,pH 6.0~6.5。The composition of the fermentation medium is as follows: 50g of soybean peptone, 10g of glucose, 17g of yeast powder, 3g of oligosaccharides, distilled water to 1000mL, pH 6.0-6.5.
冻干菌粉制备Preparation of freeze-dried bacterial powder
通过发酵液的离心、浓缩、加入冻干保护剂、真空冷冻干燥及菌粉活菌数检验等生产程序,最终制备出粉状活菌制剂。Through the production procedures such as centrifugation, concentration, addition of freeze-drying protective agent, vacuum freeze-drying, and inspection of the number of live bacteria in the bacteria powder, the powdery live bacteria preparation is finally prepared.
其中,冻干保护剂的组成如下:蔗糖15g,甘油3g,山梨醇15g,脱脂奶粉15g,蒸馏水加至250mL;菌泥(离心浓缩后的菌体)与冻干保护剂的添加比例为1∶125(g/mL),冻干保护率达到70%以上。Wherein, the composition of lyoprotectant is as follows: 15g of sucrose, 3g of glycerin, 15g of sorbitol, 15g of skimmed milk powder, and distilled water is added to 250mL; 125 (g/mL), the freeze-drying protection rate reached more than 70%.
成品检测Finished product inspection
取制备完的粉状活菌制剂1g,按国标GB/T 4789.35-2003方法测定每克菌粉中的活菌数,且菌粉中的活菌数大于109CFU/g。Take 1 g of the prepared powdery viable bacteria preparation, and measure the number of viable bacteria in each gram of bacteria powder according to the method of national standard GB/T 4789.35-2003, and the number of viable bacteria in the bacteria powder is greater than 10 9 CFU/g.
实施例2:双歧杆菌活菌制剂的制备Embodiment 2: the preparation of Bifidobacterium live bacteria preparation
菌种活化Activation of strains
将双歧杆菌冻干菌种(婴儿双歧杆菌,购自中国微生物菌种保藏管理委员会普通微生物中心,编号:CGMCC No.1.2202)划线接种于MRS固体培养基表面,37℃厌氧培养16~24h,直至固体培养基表面长出菌落,镜检观察菌体形态及纯度。Freeze-dried strains of Bifidobacterium infantis (Bifidobacterium infantis, purchased from the General Microbiology Center of China Committee for Culture Collection of Microbial Cultures, No.: CGMCC No. 1.2202) were inoculated on the surface of MRS solid medium by streaking and cultured anaerobically at 37°C for 16 ~24h, until colonies grow on the surface of the solid medium, observe the morphology and purity of the bacteria by microscopic examination.
种子液的制备Preparation of seed solution
挑取MRS固体培养基表面菌落,接种于装有5mL种子培养基的试管中,37℃厌氧培养16~24h,待活菌数达108CFU/mL,按2%(约1×106CFU/mL)接种量接种于装有150mL种子培养基的250mL锥形瓶中,37℃厌氧培养16h~24h,待活菌数达108CFU/mL,作为种子液备用。Pick the colonies on the surface of the MRS solid medium, inoculate them into a test tube containing 5 mL of seed medium, and incubate anaerobically at 37 °C for 16-24 hours . CFU/mL) inoculum amount was inoculated into a 250mL Erlenmeyer flask containing 150mL seed medium, and anaerobically cultured at 37°C for 16h to 24h, until the number of viable bacteria reached 10 8 CFU/mL, and it was used as a seed solution for later use.
种子培养基组成如下:蛋白胨10g,牛肉膏15g,酵母粉5g,葡萄糖15g,柠檬酸二铵2g,乙酸钠5g,吐温801mL,K2HPO42g,MgSO4·7H2O 0.5g,MnSO4·4H2O 0.2g,蒸馏水加至1000mL。The composition of the seed medium is as follows: peptone 10g, beef extract 15g, yeast powder 5g, glucose 15g, diammonium citrate 2g, sodium acetate 5g, Tween 801mL, K 2 HPO 4 2g, MgSO 4 7H 2 O 0.5g, MnSO 4 ·4H 2 O 0.2g, add distilled water to 1000mL.
液体深层发酵培养liquid submerged fermentation culture
将双歧杆菌种子液按3%的接种量,装液量60%,接种于5L发酵罐中,pH6.5,37℃厌氧培养24h后,测定每毫升菌液中的活菌数,待活菌数达109CFU/mL,放罐结束发酵培养。The bifidobacterium seed liquid is inoculated in a 5L fermenter with an inoculation amount of 3%, and a liquid filling amount of 60%. After anaerobic cultivation at 37°C for 24 hours, the number of viable bacteria in each milliliter of the bacterial liquid is measured. When the number of viable bacteria reaches 10 9 CFU/mL, the fermentation is completed by putting in the tank.
发酵培养基组成如下:大豆蛋白胨50g,葡萄糖10g,酵母粉17g,低聚糖3g,蒸馏水加至1000mL,pH6.5。The composition of the fermentation medium is as follows: 50 g of soybean peptone, 10 g of glucose, 17 g of yeast powder, 3 g of oligosaccharides, distilled water added to 1000 mL, pH 6.5.
冻干菌粉制备Preparation of freeze-dried bacterial powder
通过发酵液的离心、浓缩、加入冻干保护剂、真空冷冻干燥及菌粉活菌数检验等生产程序,最终制备出粉状活菌制剂。Through the production procedures such as centrifugation, concentration, addition of freeze-drying protective agent, vacuum freeze-drying, and inspection of the number of live bacteria in the bacteria powder, the powdery live bacteria preparation is finally prepared.
成品检测Finished product inspection
取制备完的粉状活菌制剂1g,按国标GB/T 4789.35-2003方法测定每克菌粉中的活菌数,测得菌粉中的活菌数大于109CFU/g。Take 1 g of the prepared powdery live bacteria preparation, measure the number of viable bacteria per gram of the bacteria powder according to the method of national standard GB/T 4789.35-2003, and the number of viable bacteria in the bacteria powder is greater than 10 9 CFU/g.
实施例3:纳豆芽孢杆菌活菌制剂的制备Embodiment 3: the preparation of bacillus natto live bacteria preparation
菌种活化Activation of strains
将纳豆芽孢杆菌冻干菌种(购自中国微生物菌种保藏管理委员会普通微生物中心,编号:CGMCC No.1.1086)划线接种于营养琼脂培养基(北京奥博星生物技术有限责任公司生产,批号为:20060808)表面,37℃好氧培养12~24h,直至培养基表面长出菌落,镜检观察菌体形态及纯度。The freeze-dried strains of Bacillus natto (purchased from the General Microbiology Center of China Microbiological Culture Collection Management Committee, number: CGMCC No. 1.1086) were streaked and inoculated on nutrient agar medium (produced by Beijing Aoboxing Biotechnology Co., Ltd., batch number For: 20060808) surface, aerobic culture at 37°C for 12 to 24 hours until colonies grow on the surface of the culture medium, and the morphology and purity of the bacteria were observed by microscopic examination.
种子液的制备挑取营养琼脂培养基表面菌落,接种于装有5mL营养肉汤培养基(北京陆桥技术有限责任公司生产,批号为:CM106)的试管中,37℃培养12~24h,待活菌数达108CFU/mL,按2%(约1×106CFU/mL)接种量接种于装有150mL营养肉汤液体培养基的250mL锥形瓶中,37℃培养12~24h,待活菌数达108CFU/mL以上,作为种子液备用。Preparation of seed solution Pick colonies on the surface of nutrient agar medium, inoculate them into a test tube containing 5 mL of nutrient broth medium (produced by Beijing Land Bridge Technology Co., Ltd., batch number: CM106), and incubate at 37°C for 12-24 hours. When the number of bacteria reaches 10 8 CFU/mL, inoculate 2% (about 1×10 6 CFU/mL) inoculum into a 250 mL Erlenmeyer flask containing 150 mL of nutrient broth liquid medium, and incubate at 37°C for 12 to 24 hours. When the number of viable bacteria reaches more than 10 8 CFU/mL, it is used as a seed solution for later use.
液体深层发酵培养liquid submerged fermentation culture
将纳豆芽孢杆菌种子液按3%的接种量接种于装有发酵培养基的5L发酵罐中,pH6.0,搅拌转速180rpm,装液量20%,37℃好氧培养24~36h后,测定每毫升菌液中的活菌数,待活菌数达108CFU/mL以上,芽孢形成率达到80%以上,放罐结束发酵培养(消泡剂为植物油,添加量1%,单位:g/ml)。The Bacillus natto seed solution was inoculated in a 5L fermenter equipped with a fermentation medium with a 3% inoculation amount, pH 6.0, a stirring speed of 180 rpm, a liquid filling volume of 20%, and aerobic cultivation at 37°C for 24 to 36 hours. Measure the number of viable bacteria per milliliter of bacterial liquid, wait until the number of viable bacteria reaches more than 10 8 CFU/mL, and the spore formation rate reaches more than 80%, put the tank to finish the fermentation culture (the defoaming agent is vegetable oil, the addition amount is 1%, unit: g/ml).
发酵培养基组成如下:蛋白胨10g,牛肉粉3.0g,NaCl 5.0g,葡萄糖1.0g,蒸馏水加至1L,pH6.0。The composition of the fermentation medium is as follows: peptone 10g, beef powder 3.0g, NaCl 5.0g, glucose 1.0g, distilled water to 1L, pH 6.0.
冻干菌粉制备Preparation of freeze-dried bacterial powder
通过发酵液的离心、浓缩、加入冻干保护剂、真空冷冻干燥及菌粉活菌数检验等生产程序,最终制备出粉状活菌制剂。Through the production procedures such as centrifugation, concentration, addition of freeze-drying protective agent, vacuum freeze-drying, and inspection of the number of live bacteria in the bacteria powder, the powdery live bacteria preparation is finally prepared.
成品检测Finished product inspection
取制备完的粉状活菌制剂1g,按国标NY-T 1461-2007方法测定每克菌粉中的活菌数,测得菌粉中的活菌数大于109CFU/g。Take 1 g of the prepared powdery live bacteria preparation, and measure the number of viable bacteria per gram of the bacteria powder according to the national standard NY-T 1461-2007 method, and the measured number of viable bacteria in the bacteria powder is greater than 10 9 CFU/g.
实施例4:复合活菌制剂的制备Embodiment 4: the preparation of composite living bacteria preparation
将三种已制备完成的粉状活菌制剂按质量比1∶1∶1的比例复配,可得到复合活菌制剂45g,经检测复配后得到的活菌制剂成品活菌总数大于1010CFU/g。Compound the three prepared powdery live bacteria preparations according to the mass ratio of 1:1:1 to obtain 45g of the compound live bacteria preparation . CFU/g.
效果:本发明的复合菌剂采用冷冻干燥保护技术制备,大幅度保证产品高活菌数的保存期,一年内产品总活菌数不低于107CFU/g。Effect: The composite microbial agent of the present invention is prepared by freeze-drying protection technology, which greatly guarantees the shelf life of the product with a high viable count, and the total viable count of the product within one year is not less than 10 7 CFU/g.
实验例1:罗伊氏乳杆菌L-HD5冻干粉制剂的应用实验Experimental example 1: Application experiment of Lactobacillus reuteri L-HD5 freeze-dried powder preparation
随机选择35日龄健康断奶仔猪36头,母系父系均为长白猪;将36头仔猪随机分为两组,试验组一为罗伊氏乳杆菌L-HD5冻干粉制剂组,饲喂仔猪日粮(不含抗生素)+罗伊氏乳杆菌L-HD5冻干粉制剂组(添加量为基础日粮的1%);试验组二为对照组,饲喂基础日粮,试验时间为30d,仔猪的免疫按猪场常规免疫程序进行。最终实验数据如下:Randomly select 36 healthy weaned piglets at the age of 35 days, all of which are Landrace pigs; the 36 piglets were randomly divided into two groups, the first test group was the Lactobacillus reuteri L-HD5 freeze-dried powder preparation group, and the piglets were fed daily Grain (without antibiotics)+Lactobacillus reuteri L-HD5 freeze-dried powder preparation group (addition amount is 1% of the basal diet); the second test group is the control group, fed with the basal diet, and the test time is 30d. The immunization of piglets was carried out according to the routine immunization procedures of the pig farm. The final experimental data is as follows:
试验组一每头仔猪平均日增重为0.415Kg,对照组为0.360Kg,试验组较对照组提高日增重7.1%。The average daily gain of each piglet in the test group 1 was 0.415Kg, and that of the control group was 0.360Kg, and the daily gain of the test group was 7.1% higher than that of the control group.
试验组一每头仔猪平均日耗料量为0.668Kg,对照组为0.700Kg,试验组较对照组降低日耗料量2.3%。The average daily feed consumption per piglet in the test group 1 was 0.668Kg, and that in the control group was 0.700Kg. Compared with the control group, the daily feed consumption in the test group was reduced by 2.3%.
试验组一腹泻率为12.5%,对照组为32.2%,试验组较对照组降低腹泻率19.7%。The diarrhea rate of the test group 1 was 12.5%, and that of the control group was 32.2%. Compared with the control group, the rate of diarrhea in the test group was reduced by 19.7%.
动物饲喂实验表明,对断奶仔猪饲喂猪源罗伊氏乳杆菌L-HD5冻干粉制剂可提高断奶仔猪日增重,降低日耗料量和腹泻发病率。Animal feeding experiments showed that feeding pig-derived Lactobacillus reuteri L-HD5 freeze-dried powder preparation to weaned piglets can increase the daily weight gain of weaned piglets, reduce daily feed consumption and the incidence of diarrhea.
实验例2Experimental example 2
随机选择35日龄健康断奶仔猪54头,母系父系均为长白猪;将54头仔猪随机分为三组,试验组一为罗伊氏乳杆菌L-HD5冻干粉制剂组,饲喂仔猪日粮(不含抗生素)+罗伊氏乳杆菌L-HD5冻干粉制剂组(添加量为基础日粮的1%);试验组二为复合活菌制剂组,饲喂仔猪日粮(不含抗生素)+实施例4所制得的复合活菌制剂(添加量为基础日粮的1%);试验组三为对照组,饲喂基础日粮,试验时间为30d,仔猪的免疫按猪场常规免疫程序进行。最终试验数据如下:Randomly select 54 healthy weaned piglets at the age of 35 days, all of which are landrace pigs; the 54 piglets are randomly divided into three groups, the first test group is the Lactobacillus reuteri L-HD5 freeze-dried powder preparation group, and the piglets are fed every day. grain (without antibiotics)+Lactobacillus reuteri L-HD5 freeze-dried powder preparation group (the addition amount was 1% of the basic diet); the second experimental group was the compound live bacteria preparation group, and the piglets were fed with the diet (without Antibiotic)+compound live bacteria preparation (addition amount is 1% of basal ration) made in embodiment 4; Test group three is control group, feeds basal ration, and test time is 30d, and the immunity of piglet is according to pig farm Routine immunization procedures were performed. The final test data is as follows:
试验组一每头仔猪平均日增重为0.415Kg,试验组二每头仔猪平均日增重为0.563Kg,对照组为0.360Kg,试验组一较对照组提高日增重7.1%,试验组二较对照组提高日增重22%。The average daily gain of each piglet in the test group 1 was 0.415Kg, the average daily gain of each piglet in the test group 2 was 0.563Kg, and that of the control group was 0.360Kg. Compared with the control group, the test group 1 increased the daily gain by 7.1%, and the test group 2 Compared with the control group, the daily weight gain was increased by 22%.
试验组一每头仔猪平均日耗料量为0.668Kg,试验组二每头仔猪平均日耗料量为0.690Kg,对照组为0.700Kg,试验组一较对照组降低日耗料量2.3%,试验组二较对照组降低日耗料量0.7%。The average daily feed consumption per piglet in test group 1 was 0.668Kg, the average daily feed consumption per piglet in test group 2 was 0.690Kg, and that in the control group was 0.700Kg. Compared with the control group, the daily feed consumption in test group 1 was reduced by 2.3%. Compared with the control group, the experimental group 2 reduced the daily feed consumption by 0.7%.
试验组一腹泻率为12.5%,试验组二腹泻率为9.6%,对照组为32.2%,试验组较对照组降低腹泻率19.7%,试验组二较对照组降低腹泻率22.6%。The diarrhea rate of the first test group was 12.5%, that of the second test group was 9.6%, and that of the control group was 32.2%.
应用实验表明,对断奶仔猪饲喂复合活菌制剂可显著提高断奶仔猪日增重,降低日耗料量和腹泻发病率。Application experiments show that feeding compound live bacteria preparations to weaned piglets can significantly increase the daily weight gain of weaned piglets, reduce daily feed consumption and the incidence of diarrhea.
复合活菌制剂较单一罗伊氏乳杆菌制剂益生效用显著。这可能是由于复合活菌制剂中的三种益生菌具有协同增效作用。The probiotic effect of compound live bacteria preparation is more significant than single Lactobacillus reuteri preparation. This may be due to the synergistic effect of the three probiotics in the compound live bacteria preparation.
首先,纳豆芽孢杆菌属于好氧菌,进入肠道后在生长繁殖过程中消耗环境内的氧气,可以抑制好氧致病菌的生长,但有助于罗伊氏乳杆菌和双歧杆菌等厌氧菌的繁殖;其次,罗伊氏乳杆菌和双歧杆菌的生长又增加了肠道内的酸度,更加强了对致病菌生长的抑制。所以复合活菌制剂较单一菌制剂表现出了更显著的益生效用。First of all, Bacillus natto belongs to aerobic bacteria. After entering the intestinal tract, it consumes oxygen in the environment during the growth and reproduction process, which can inhibit the growth of aerobic pathogenic bacteria, but helps Lactobacillus reuteri and Bifidobacteria, etc. The reproduction of anaerobic bacteria; secondly, the growth of Lactobacillus reuteri and bifidobacteria increases the acidity in the intestinal tract, which further strengthens the inhibition of the growth of pathogenic bacteria. Therefore, the compound live bacteria preparation showed a more significant probiotic effect than the single bacteria preparation.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105174270A CN101974463B (en) | 2010-10-19 | 2010-10-19 | Lactobacillus reuteri and composite viable bacteria preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105174270A CN101974463B (en) | 2010-10-19 | 2010-10-19 | Lactobacillus reuteri and composite viable bacteria preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101974463A true CN101974463A (en) | 2011-02-16 |
CN101974463B CN101974463B (en) | 2012-05-09 |
Family
ID=43574372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105174270A Expired - Fee Related CN101974463B (en) | 2010-10-19 | 2010-10-19 | Lactobacillus reuteri and composite viable bacteria preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101974463B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102304489A (en) * | 2011-09-23 | 2012-01-04 | 北京龙科方舟生物工程技术中心 | Lactobacillus reuteri strain and application thereof |
CN106359904A (en) * | 2016-11-25 | 2017-02-01 | 广东省农业科学院动物科学研究所 | Application of lactobacillus reuteri in replacement of feed antibiotic |
CN107047933A (en) * | 2016-08-30 | 2017-08-18 | 安徽省农业科学院畜牧兽医研究所 | A kind of preparation method and application of solid-state lactobacillus reuteri probiotics |
CN107475117A (en) * | 2017-07-03 | 2017-12-15 | 桐乡恒基生物股份有限公司 | A kind of freeze drying protectant for lactobacillus reuteri and lyophilized store method |
CN108102976A (en) * | 2018-02-05 | 2018-06-01 | 富乐顿生物工程科技(北京)有限公司 | A kind of space lactobacillus reuteri SS23-27 and its application in purebred probiotic yogurt is prepared |
CN110269175A (en) * | 2019-06-05 | 2019-09-24 | 嘉兴浙华质检技术服务有限公司 | A kind of spraying micro-ecology preparation and preparation method thereof for feed anticorrosion |
CN111789871A (en) * | 2014-05-05 | 2020-10-20 | G·莫格纳 | Use of a composition containing Lactobacillus reuteri LER03 for preparing an antiviral and/or antibacterial agent |
CN115141765A (en) * | 2022-05-26 | 2022-10-04 | 广州朴成生物科技有限公司 | Composite microecological preparation for repairing intestinal tract injury caused by piglet weaning stress and preparation method thereof |
CN115141766A (en) * | 2022-05-26 | 2022-10-04 | 广州朴成生物科技有限公司 | Application of composite microecological preparation in preparation of preparation for repairing intestinal tract injury caused by weaning stress of piglets |
CN117511762A (en) * | 2023-09-14 | 2024-02-06 | 石河子大学 | A reuterin-producing halotolerant Lactobacillus reuteri and its application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101461453A (en) * | 2009-01-15 | 2009-06-24 | 润盈生物工程(上海)有限公司 | Composite microbial feed additive for beasts and birds and production method |
CN101530165A (en) * | 2009-04-23 | 2009-09-16 | 上海谱莱生物技术有限公司 | Animal feed composite microecologic agent |
CN101575582A (en) * | 2008-05-08 | 2009-11-11 | 景岳生物科技股份有限公司 | Lactobacillus isolate with anti-inflammatory activity and use thereof |
-
2010
- 2010-10-19 CN CN2010105174270A patent/CN101974463B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101575582A (en) * | 2008-05-08 | 2009-11-11 | 景岳生物科技股份有限公司 | Lactobacillus isolate with anti-inflammatory activity and use thereof |
CN101461453A (en) * | 2009-01-15 | 2009-06-24 | 润盈生物工程(上海)有限公司 | Composite microbial feed additive for beasts and birds and production method |
CN101530165A (en) * | 2009-04-23 | 2009-09-16 | 上海谱莱生物技术有限公司 | Animal feed composite microecologic agent |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102304489B (en) * | 2011-09-23 | 2013-06-12 | 北京龙科方舟生物工程技术有限公司 | Lactobacillus reuteri strain and application thereof |
CN102304489A (en) * | 2011-09-23 | 2012-01-04 | 北京龙科方舟生物工程技术中心 | Lactobacillus reuteri strain and application thereof |
CN111789871A (en) * | 2014-05-05 | 2020-10-20 | G·莫格纳 | Use of a composition containing Lactobacillus reuteri LER03 for preparing an antiviral and/or antibacterial agent |
CN107047933B (en) * | 2016-08-30 | 2019-11-12 | 安徽省农业科学院畜牧兽医研究所 | A kind of preparation method and application of solid-state lactobacillus reuteri probiotics |
CN107047933A (en) * | 2016-08-30 | 2017-08-18 | 安徽省农业科学院畜牧兽医研究所 | A kind of preparation method and application of solid-state lactobacillus reuteri probiotics |
CN106359904A (en) * | 2016-11-25 | 2017-02-01 | 广东省农业科学院动物科学研究所 | Application of lactobacillus reuteri in replacement of feed antibiotic |
CN107475117A (en) * | 2017-07-03 | 2017-12-15 | 桐乡恒基生物股份有限公司 | A kind of freeze drying protectant for lactobacillus reuteri and lyophilized store method |
CN108102976B (en) * | 2018-02-05 | 2020-10-27 | 富乐顿生物工程科技(北京)有限公司 | Lactobacillus reuteri SS23-27 and application thereof in preparation of pure probiotic yogurt |
CN108102976A (en) * | 2018-02-05 | 2018-06-01 | 富乐顿生物工程科技(北京)有限公司 | A kind of space lactobacillus reuteri SS23-27 and its application in purebred probiotic yogurt is prepared |
CN110269175A (en) * | 2019-06-05 | 2019-09-24 | 嘉兴浙华质检技术服务有限公司 | A kind of spraying micro-ecology preparation and preparation method thereof for feed anticorrosion |
CN115141765A (en) * | 2022-05-26 | 2022-10-04 | 广州朴成生物科技有限公司 | Composite microecological preparation for repairing intestinal tract injury caused by piglet weaning stress and preparation method thereof |
CN115141766A (en) * | 2022-05-26 | 2022-10-04 | 广州朴成生物科技有限公司 | Application of composite microecological preparation in preparation of preparation for repairing intestinal tract injury caused by weaning stress of piglets |
CN117511762A (en) * | 2023-09-14 | 2024-02-06 | 石河子大学 | A reuterin-producing halotolerant Lactobacillus reuteri and its application |
CN117511762B (en) * | 2023-09-14 | 2024-11-05 | 石河子大学 | Salt-tolerant lactobacillus reuteri for producing reuterin and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101974463B (en) | 2012-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101974463B (en) | Lactobacillus reuteri and composite viable bacteria preparation thereof | |
CN102399733B (en) | Lactobacillus johnsonii, microbial inoculum, application and premix thereof | |
CN102409015B (en) | Composite micro-ecological preparation as well as premixed material and application of preparation in feed additive | |
CN103981117B (en) | One plant height resistance enterococcus faecium and its cultural method and application | |
CN102293340B (en) | Compound premix able to improve immune function for pigs | |
CN109749957B (en) | Preparation and application of lactobacillus gasseri preparation with aquatic pathogenic bacteria antagonistic property | |
CN113604405B (en) | Preparation method and application of enterococcus faecium bacterial agent | |
CN102094054B (en) | Production method of Bacillus subtilis antimicrobial lipopeptide and application of Bacillus subtilis antimicrobial lipopeptide in piglet feeds | |
CN103865854B (en) | A kind of compound micro-ecological preparation and preparation method thereof | |
CN106858066A (en) | Collaboration promotes the additive and application method of proliferation of intestinal probiotics and field planting | |
CN107164274A (en) | A kind of lactic acid bacteria composite fungicide and its preparation method and application | |
CN109593666B (en) | Composite microecological preparation and preparation method and application thereof | |
CN106906154A (en) | One lactobacillus plantarum strain and its feed addictive and feed | |
CN116083262A (en) | Lactobacillus plantarum strain with aquatic pathogenic bacteria antagonistic property and preparation and application of preparation thereof | |
CN102505003A (en) | High-density fermenting method of bacillus coagulans for livestock and poultry, as well as preparation prepared by method and application thereof | |
CN102232479B (en) | A kind of preparation technology of bacillus feed additive | |
CN111903838A (en) | Yeast culture and compound lactobacillus preparation and preparation method thereof | |
CN102965316B (en) | Bacteriocin containing class and the feed addictive of Pediococcus acidilactici, premix and batch | |
CN115094012B (en) | Preparation method and application of bacillus coagulans BC-HYC strain microbial inoculum | |
CN103013890B (en) | Method of culturing lactobacillus and bacillus in mixing way | |
CN101229196B (en) | Microecologic agent preventing grice diarrhoea and preparing method thereof | |
CN102907585B (en) | A kind of middle pig probiotic vitamin premix and batch | |
CN106635886A (en) | Method for reducing egg cholesterol by utilizing lactobacillus paracasei of bile salt producing hydrolase | |
CN107586742A (en) | The bacillus amyloliquefaciens of one plant height production levulan and its application | |
CN102860411A (en) | Lactobacillus rhamnosus probiotic and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120509 Termination date: 20131019 |